Prompt

How do I ensure my protocol execution with an electronic data capture platform is compliant with 21 CFR Part 11?

Pharmaceuticals / Big Pharma1 observationLast seen Aug 14, 2026

Latest observation

Aug 14, 2026OpenAI APIWeb search: off

To make protocol execution in an electronic data capture (EDC) platform compliant with 21 CFR Part 11, you need more than just software features—you need a validated system, controlled processes, and documented oversight.

Here’s a practical checklist:

1) Use a validated system

  • Validate the EDC system for its intended use.
  • Document testing for:
    • user access controls
    • audit trails
    • data entry/editing
    • e-signatures
    • report generation
    • system security and backups
  • Keep validation records and change control documentation.

2) Control user access tightly

  • Give each user a unique ID.
  • Use role-based permissions (e.g., site staff, monitor, data manager, admin).
  • Restrict access to only what each person needs.
  • Remove access promptly when users change roles or leave.

3) Use secure electronic signatures

  • E-signatures should be:
    • unique to one individual
    • linked to their identity
    • non-reusable by others
    • protected with strong authentication
  • Have documented procedures for signature meaning (e.g., approval, certification, review).

4) Maintain audit trails

  • The system should automatically record:
    • who entered or changed data
    • when it happened
    • what was changed
    • the prior value and reason for change, when applicable
  • Audit trails must be secure, time-stamped, and reviewable.

5) Ensure data integrity and security

  • Protect data from unauthorized alteration or deletion.
  • Use encryption in transit and at rest where appropriate.
  • Implement backup, disaster recovery, and business continuity plans.
  • Regularly test restoration of backups.

6) Establish SOPs and training

  • Have written SOPs for:
    • system use
    • data entry and corrections
    • e-signature use
    • audit trail review
    • user access management
    • incident handling
    • archival/retention
  • Train all users before they are granted access, and keep training records.

7) Review and reconcile data regularly

  • Monitor data entry for completeness and consistency.
  • Review audit trails for unusual or unauthorized changes.
  • Reconcile source data, EDC data, and any imported data.

8) Maintain record retention and retrieval

  • Ensure records are retained for the required period.
  • You must be able to retrieve readable, accurate copies throughout retention.
  • Keep metadata and audit trails with the records.

9) Manage vendors properly

If you use a third-party EDC provider:

  • Perform vendor qualification due diligence.
  • Have a quality agreement or contract defining responsibilities.
  • Confirm the vendor supports Part 11 requirements.
  • Review their validation, security, and support processes.

10) Assess whether Part 11 applies

Part 11 applies when you use electronic records/signatures in regulated activities under FDA oversight. You should confirm:

  • whether your study/activity falls under FDA-regulated use
  • whether paper records and true copies are being used
  • whether any exception or risk-based approach applies

Practical “minimum evidence” to keep

You should be able to produce:

  • validation summary/report
  • user access matrix and access logs
  • SOPs and training records
  • audit trail review procedures and evidence
  • backup/restore testing results
  • vendor qualification package
  • e-signature policy and certification records
  • change control records

Best practice

Use a risk-based validation approach aligned with your protocol and data criticality. For example, focus more testing on functionality that affects:

  • primary endpoint data
  • safety data
  • signatures/approvals
  • blinding/randomization
  • data transfers and imports

If you want, I can also provide:

  1. a Part 11 compliance checklist for EDC studies,
  2. a vendor qualification questionnaire, or
  3. a SOP outline for protocol execution in EDC.

Brands

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.